You are here:

1. Homepage
2. Pharmacovigilance
3. Information on Risks

Dear Doctor Letter (Rote-Hand-Brief) on VOLIBRIS^® (ambrisentan): New Contraindication

VOLIBRIS^® (ambrisentan) must not be given to patients with idiopathic pulmonary fibrosis (IPF).
A  Rote-Hand-Brief on Volibris® (file size: 1 MB) will be circulated.